ClinicalTrials.Veeva

Menu

Additive Effect of Intravenous Acetaminophen on Postoperative Pain Control

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Postoperative Pain
Gynecologic Disease

Treatments

Drug: Acetaminophen

Study type

Interventional

Funder types

Other

Identifiers

NCT03644147
H-1807-151-961

Details and patient eligibility

About

This study aimed to evaluate the additive effect of acetaminophen on postoperative pain control in patients receiving nefopam and fentanyl-based patient-controlled analgesia.

Participants undergoing laparoscopic hysterectomy will be randomly assigned to treatment group or control group. After end of surgery, acetaminophen or normal saline (placebo) will be administered intravenously depending on the group assigned.

Enrollment

84 patients

Sex

Female

Ages

19 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing total laparoscopic hysterectomy due to uterine myoma, cervical cancer, endometriosis, uterine prolapse

Exclusion criteria

  • Liver disease (aspartate transaminase OR alanine transaminase > 80 IU/L)
  • Chronic kidney disease (GFR < 30 ml/min/1.73m2)
  • History of drug allergy
  • Chronic pain lasting more than 3 months
  • Conversion to laparotomy
  • Complex surgery (co-operation with colon surgeon or urologist)
  • Limitation in expressing pain

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

84 participants in 2 patient groups

Treatment
Experimental group
Description:
Patients in this group will receive 1 gram of acetaminophen intravenously after the end of surgery.
Treatment:
Drug: Acetaminophen
Control
No Intervention group
Description:
Patients in this group will receive 100 ml of normal saline intravenously after the end of surgery.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems